Clinical Trials
Search our team at AdventHealth Research Institute
Showing 1 - 5 of 5 clinical trials matching your search
-
NCT06527157
PROspective ACcrual To Investigate reprOductive cancers in womeN.
This study is currently enrolling.Associated Conditions: WomensResearch Area: Pediatric Research and Clinical TrialsResearch Location: OrlandoThe purpose of this clinical research study is to develop a non-invasive test to tell future women that they do not have endometrial cancer. -
NCT06690775
A Phase 2 Study Evaluating the Efficacy and Safety of TORL-1-23 in Women With Advanced Platinum-Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal and Fallopian Tube Cancers) Expressing Claudin 6
This study is currently enrolling.Associated Conditions: GynecologyResearch Area: Colorado Cancer ResearchResearch Location: Porter, Colorado -
NCT05281471
A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec followed by Platinum-doublet Chemotherapy and Bevacizumab Compared with Platinum-doublet Chemotherapy and Bevacizumab in Women with Platinum-Resistant/Refractory Ovarian Cancer (OnPrime Study
This study is currently enrolling.Associated Conditions: GynecologyResearch Area: Clinical Cancer ResearchResearch Location: OrlandoYou are invited to take part in a research study. This research study is studying Olvi-Vec as a possible treatment for platinum-resistant or platinum-refractory ovarian cancer including fallopian tube... -
NCT06492616
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence - A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT).
This study is currently enrolling.Associated Conditions: BreastResearch Area: Colorado Cancer ResearchResearch Location: Porter, ColoradoThe purpose of this clinical study is to test the safety and efficacy of elacestrant compared to standard of care therapy in participants with node-positive, estrogen receptor-positive (ER+), HER2... -
NCT06492616
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence - A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)
This study is currently enrolling.Associated Conditions: BreastResearch Area: Clinical Cancer ResearchResearch Location: AltamonteIn this study, we are testing a new endocrine therapy, called elacestrant, that is an endocrine therapy that stops hormones from attaching to cancer cells and helping them grow. Researchers would like...
